No specific molecular host target identified

The designation 'No specific molecular host target identified' is a classification used in pharmacological databases such as ChEMBL and DrugBank to indicate that a drug's therapeutic effect is not mediated through a specific, well-defined molecular entity like a receptor, enzyme, or ion channel (ChEMBL Database, 2024; DrugBank Online, 2024). This category typically encompasses agents that act through non-specific physical or chemical mechanisms, including osmotic laxatives that alter water distribution or antacids that neutralize gastric acid through direct chemical reaction (Goodman & Gilman's The Pharmacological Basis of Therapeutics, 13th Ed.). It may also be applied to drugs where the clinical mechanism is recognized but the exact molecular binding partner remains uncharacterized or unknown despite scientific investigation (Nature Reviews Drug Discovery, 2011). Because these substances do not interact with a discrete target, they often lack the high selectivity and predictable structure-activity relationships characteristic of modern targeted therapies (IUPHAR/BPS Guide to Pharmacology, 2023). For biotech analysts, this classification highlights a reliance on broad physiological changes rather than precise molecular modulation, which presents unique challenges for safety assessment and the development of next-generation analogs (FDA Guidance on Non-clinical Safety Studies, 2021).

Other names

Unknown targetNon-specific targetUncharacterized mechanismTarget unknownNon-molecular target

Non-specific physical or chemical interaction